Delivering DNA to immune cells is the trickiest part of developing new gene-based therapies.
Researchers are trying to boost the power of our immune system by genetically altering our white blood cells and transforming them into super-soldiers to fight cancer.
For developing countries in Africa immunotherapy solutions is important given the high cost of cancer drugs.
Most cancer research has been done in Europe, there's minimal data on African populations.
A woman holds her stomach in agony from ulcerative colitis.
Emily Frost / Shutterstock.com
Cancer immunotherapy is a revolutionary treatment for many but it can cause nasty side effects like inflammation of the colon that can derail treatment. Could the solution be a fecal transplant?
James P. Allison and Tasuku Honjo win the 2018 Nobel Prize in Physiology or Medicine for their foundational work on cancer immunotherapy.
The University of Texas MD Anderson Cancer Center and Kyoto University
James Allison and Tasuku Honjo won the 2018 Nobel Prize in Physiology or Medicine for encouraging immune cells to attack cancer. See how their work has revolutionized cancer therapies and medicine.
Applications to list drugs on the PBS are usually submitted by the manufacturers of those drugs.
Some argue the current system of subsidising drugs in Australia needs changing to accommodate new cancer therapies. But two recent drug listings show the current system is working perfectly well.
Some of the notable additions to the PBS include drugs to treat eye and HIV infections, cystic fibrosis, multiple sclerosis, and cancer.
An independent expert provides his pick of the most notable drugs added to the PBS on May 1, 2017.
Complex enough – without cancer.
By tampering with the machinery which allows aggressive cancer cells to adapt, we can disrupt their ecosystem.
New immunotherapy drugs that enhance the body's natural ability to fight cancer offer several key advantages over previous treatments.
Take one healthy T cell … and modify some things.
If you can't find the specific T cells you need to fight a cancer, make them.
2014: the year crystallography went mainstream.
’Tis the season for listicles rounding up the stories of the year. So with, the authority vested in me, here is a selection of six top, bottom and forgotten science stories of 2014. Bounciest landing The…
Pancreatic cancer with other cells.
The trouble with treating cancer is that each type has its own quirks. The quirks of pancreatic cancer make it one of the most lethal. The survival period after diagnosis is only four to six months. The…